Sage Therapeutics sponsored trial for Parkinson’s Disease Mild Cognitive Impairment (PD-MCI)

Sage Therapeutics sponsored trial for Parkinson’s Disease Mild...see more Cognitive Impairment (PD-MCI): Research study for adults ages 50 to 75 years old who have been diagnosed with PD-MCI. The purpose of this study is to evaluate the safety and tolerability of an investigational medication. Participants must […]

Read More

Boxing for Parkinson’s Disease

Boxing and Parkinson’s Disease We know without a doubt that exercise is important for people with Parkinson’s disease (PD). ...see more Various types of exercise and movement can help people improve their balance, strength, mobility, flexibility, endurance and walking ability. Studies also reveal that exercise can help improve cognition, depression, fatigue, and sleep. We have discussed exercise in […]

Read More

APDA CENTER AT BRIGHAM AND WOMEN’S HOSPITAL REPORTS EXCITING CORRELATION BETWEEN GLUCOCEREBROSIDASE ACTIVITY AND PARKINSON’S DISEASE

In an exciting new study, researchers at the APDA-funded Center studied the relationship between the activity of the glucocerebrosidase...see more (GBA) enzyme and the risk of Parkinson’s disease (PD). This insight may help shed light on possible future treatments. The glucocerebrosidase (GBA) enzyme, encoded by the GBA gene, is a protein used by the body to […]

Read More